Key result
Pretreatment with mefloquine potentiated the QTc-prolonging effects of halofantrine by increasing its blood concentrations two to six times compared to halofantrine alone.
Why the study?
Does mefloquine pretreatment potentiate halofantrine-induced QTc prolongation in anaesthetized rabbits?
Does mefloquine pretreatment potentiate halofantrine-induced QTc prolongation in anaesthetized rabbits?
Mefloquine potentiates halofantrine-induced QTc prolongation by increasing circulating concentrations of halofantrine, highlighting a significant pharmacokinetic drug-drug interaction.
Answers are grounded in this paper and cite their sources.
Mefloquine-halofantrine QTc interaction merits preclinical vigilance; leaves open human translation and clinical relevance.
The antimalarial drug halofantrine can prolong the QT interval and this may be enhanced by prior use of mefloquine. This possible interaction has been investigated by examining the effects of halofantrine and mefloquine alone and in combination. 2. In anaesthetized rabbits (n=6 per group), halofantrine given as bolus doses of 1, 3, 10, and 30 mg kg(-1) at 25 min intervals dose-dependently prolonged the rate-corrected QT (QTc) interval from 313+/-12 ms pre-drug to 410+/-18 ms after the highest dose. Similar doses of mefloquine did not alter QTc intervals significantly. The highest dose of mefloquine (30 mg kg(-1)) caused cardiac contractile failure. 3. Pretreatment with 3 mg kg(-1) mefloquine 25 min before the first dose of halofantrine potentiated the effects of all doses of halofantrine on QTc intervals. 4. The blood concentrations of halofantrine were two to six times higher in the group pretreated with mefloquine compared to the halofantrine alone group; e.g. 1.03+/-0.17 and 0.16+/-0.02 microM respectively after 1 mg kg(-1) halofantrine. There was a significant correlation between blood halofantrine concentrations and QTc intervals (r=0.673). Even after making allowance for overestimation of the potency of halofantrine that may result from the hypokalaemia that is prevalent in anaesthetized rabbits, these effects occurred with concentrations of halofantrine that are found in clinical use. 5. These data indicate clearly that while mefloquine does not alter QTc intervals itself, it does enhance the effects of halofantrine by increasing the circulating concentration of halofantrine.
No takes yet. Share an insight, caveat, or question.
Lightbown et al. (2001) studied QTc prolongation. Mefloquine pretreatment followed by halofantrine vs. Halofantrine alone or mefloquine alone was evaluated on QTc interval and blood halofantrine concentrations. Pretreatment with mefloquine potentiated the QTc-prolonging effects of halofantrine by increasing its blood concentrations two to six times compared to halofantrine alone.
Synapse has enriched 10 related papers. Consider them for comparative context: